share_log

信邦制药(002390.SZ):2023年度净利润增28.02%至2.87亿元 拟10派0.6元

Xinbang Pharmaceutical (002390.SZ): Net profit increased by 28.02% in 2023 to 287 million yuan, plans to distribute 10.0.6 yuan

Gelonghui Finance ·  Apr 15 07:00

Gelonghui, April 15 | Xinbang Pharmaceutical (002390.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 6.461 billion yuan, up 1.75% year on year; net profit attributable to shareholders of listed companies was 287 million yuan, up 28.02% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 268 million yuan, up 19.43% year on year; basic income per share was 0.15 yuan; it plans to distribute a cash dividend of 0.60 yuan (tax included) to all shareholders for every 10 shares.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment